Breast cancer is classified into the type A group (estrogen receptor+, HER2−), the type B group (estrogen receptor+, HER2+), the HER2 overexpression group (estrogen receptor−, HER2+), and the estrogen by RNA microarray method. Here, ERBB2 is linked to breast carcinoma.